Wall Street analysts expect Proto Labs Inc (NYSE:PRLB) to report sales of $98.81 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Proto Labs’ earnings. The highest sales estimate is $104.22 million and the lowest is $88.00 million. Proto Labs reported sales of $80.17 million in the same quarter last year, which indicates a positive year over year growth rate of 23.3%. The company is expected to issue its next earnings results before the market opens on Thursday, April 26th.
On average, analysts expect that Proto Labs will report full year sales of $439.43 million for the current year, with estimates ranging from $438.48 million to $440.00 million. For the next fiscal year, analysts expect that the firm will post sales of $499.00 million per share, with estimates ranging from $491.10 million to $506.90 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that follow Proto Labs.
Proto Labs (NYSE:PRLB) last posted its earnings results on Thursday, February 8th. The industrial products company reported $0.53 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.48 by $0.05. The company had revenue of $94.18 million for the quarter, compared to analyst estimates of $92.20 million. Proto Labs had a return on equity of 12.22% and a net margin of 15.03%. The company’s revenue for the quarter was up 30.2% on a year-over-year basis. During the same quarter last year, the company earned $0.41 earnings per share.
Separately, Zacks Investment Research lowered Proto Labs from a “buy” rating to a “hold” rating in a report on Wednesday, December 27th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $85.00.
Shares of Proto Labs stock opened at $119.40 on Friday. The firm has a market cap of $3,190.48, a P/E ratio of 61.87, a price-to-earnings-growth ratio of 2.42 and a beta of 0.96. Proto Labs has a 12 month low of $49.30 and a 12 month high of $126.95.
In related news, Director John B. Goodman sold 2,715 shares of Proto Labs stock in a transaction on Monday, February 12th. The stock was sold at an average price of $106.79, for a total transaction of $289,934.85. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director John B. Goodman sold 1,114 shares of the business’s stock in a transaction on Wednesday, March 14th. The shares were sold at an average price of $122.71, for a total value of $136,698.94. Following the completion of the sale, the director now owns 11,091 shares in the company, valued at $1,360,976.61. The disclosure for this sale can be found here. Insiders have sold 5,720 shares of company stock worth $627,080 over the last quarter. 7.78% of the stock is currently owned by corporate insiders.
Several institutional investors and hedge funds have recently modified their holdings of PRLB. Arrowstreet Capital Limited Partnership raised its stake in shares of Proto Labs by 585.4% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 175,884 shares of the industrial products company’s stock valued at $18,116,000 after buying an additional 150,222 shares during the period. Brown Capital Management LLC raised its stake in shares of Proto Labs by 2.4% in the fourth quarter. Brown Capital Management LLC now owns 3,896,579 shares of the industrial products company’s stock valued at $401,348,000 after buying an additional 92,395 shares during the period. Conestoga Capital Advisors LLC raised its stake in shares of Proto Labs by 16.1% in the fourth quarter. Conestoga Capital Advisors LLC now owns 588,419 shares of the industrial products company’s stock valued at $60,607,000 after buying an additional 81,745 shares during the period. BlackRock Inc. raised its stake in shares of Proto Labs by 2.4% in the fourth quarter. BlackRock Inc. now owns 3,053,965 shares of the industrial products company’s stock valued at $314,558,000 after buying an additional 72,731 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of Proto Labs by 12.3% in the third quarter. Dimensional Fund Advisors LP now owns 438,869 shares of the industrial products company’s stock valued at $35,240,000 after buying an additional 48,172 shares during the period. Hedge funds and other institutional investors own 98.26% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Proto Labs Inc (PRLB) Expected to Post Quarterly Sales of $98.81 Million” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/04/15/proto-labs-inc-prlb-expected-to-post-quarterly-sales-of-98-81-million.html.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
Get a free copy of the Zacks research report on Proto Labs (PRLB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.